HomeAPTO • NASDAQ
Follow
Aptose Biosciences Inc
Previous close
$1.50
Day range
$1.50 - $1.70
Year range
$1.36 - $10.12
Market cap
26.24M USD
Avg Volume
77.61K
P/E ratio
-
Dividend yield
-
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.68M | 16.51% |
Net income | -11.45M | -17.08% |
Net profit margin | — | — |
Earnings per share | -2.42 | -7.50% |
EBITDA | -11.66M | -16.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.72M | -68.02% |
Total assets | 20.88M | -63.41% |
Total liabilities | 13.10M | 28.00% |
Total equity | 7.78M | — |
Shares outstanding | 7.82M | — |
Price to book | 1.46 | — |
Return on assets | -123.08% | — |
Return on capital | -244.62% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -11.45M | -17.08% |
Cash from operations | -10.54M | -50.97% |
Cash from investing | 12.95M | 355.08% |
Cash from financing | 4.90M | 23,242.86% |
Net change in cash | 7.32M | 160.78% |
Free cash flow | -6.19M | -80.72% |
About
Founded
1986
Headquarters
Website
Employees
35